Jun, MAPK8 and TP53 are related to MAPK signaling pathway, which suggests that MAPK signaling pathway may play a central role in the treatment of oral squamous cell carcinoma by triptolide. Here, JUN is linked to oral cavity squamous cell carcinoma.